ERT provides unparalleled service and reliable solutions with a common purpose - to help our customers capture high quality patient safety and efficacy endpoint data as they develop new treatments to improve and save lives. Our important work sets the industry standard. Our team provides proven scientific and regulatory leadership to biopharmaceutical, Contract Research Organizations (CROs) and medical device companies around the world. Our global clients rely upon our expertise - in cardiac safety, respiratory service, suicidal risk assessment, and Clinical Outcome Assessments (COAs) -- which includes patient, clinician, and observer reported outcomes - to expedite their clinical research studies and empower them to make their expert decisions, more quickly and accurately, related to their product development and approval efforts. We are also proud to be named one of Deloitte's “Fast 50” - one of the top 50 fastest growing companies in our region within the United States.